HF
ONC icon

HRT Financial’s BeOne Medicines Ltd ONC Stock Holding History

HRT Financial’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,676
Closed -$1.27M – 3751
2025
Q1 		$1.27M Sell
4,676
-14,568
-76% -$3.41M 0.01% 1016
2024
Q4 		$3.55M Buy
19,244
+14,810
+334% +$3.03M 0.02% 516
2024
Q3 		$995K Buy
+4,434
New +$798K ﹤0.01% 1238
2021
Q4 		– Sell
-735
Closed -$266K – 4240
2021
Q3 		$266K Buy
+735
New +$240K ﹤0.01% 2498
2020
Q2 		– Sell
-1,785
Closed -$219K – 1814
2020
Q1 		$219K Buy
+1,785
New +$279K 0.01% 557

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial's ONC Position: Q2 2025 in Review

HRT Financial sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 4,676 shares — an estimated $1.27M sold.

HRT Financial first reported a position in ONC in Q1 2020 and held it in 5 quarters. The position peaked at $3.55M in Q4 2024. 245 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • HRT Financial reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 4,676 BeOne Medicines Ltd shares in Q2 2025, an estimated $1.27M.
  • HRT Financial first reported a position in BeOne Medicines Ltd in Q1 2020 and held it in 5 quarters.
  • HRT Financial's BeOne Medicines Ltd position peaked at $3.55M in Q4 2024.
  • 245 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.